Evidence map›Paper›PMID 34571877›Full record

ArticleCells2021

Glucocorticoid-Induced Leucine Zipper-Mediated TLR2 Downregulation Accounts for Reduced Neutrophil Activity Following Acute DEX Treatment.

Erika Ricci, Elena Roselletti, Marco Gentili, Samuele Sabbatini, Stefano Perito, Carlo Riccardi, Graziella Migliorati, Claudia Monari, Simona Ronchetti

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Hormonal interventions in skin wounds - a mini review.Molecular medicine (Cambridge, Mass.) · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Association of GILZ with MUC2, TLR2, and TLR4 in Inflammatory Bowel Disease.International journal of molecular sciences · 2023
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Erika RicciDepartment of Medicine and Surgery, Pharmacology Division, University of Perugia, 06132 Perugia, Italy.
Elena RosellettiDepartment of Medicine and Surgery, Medical Microbiology Division, University of Perugia, 06132 Perugia, Italy.
Marco GentiliDepartment of Medicine and Surgery, Pharmacology Division, University of Perugia, 06132 Perugia, Italy.ORCID 0000-0002-2305-4488
Samuele SabbatiniDepartment of Medicine and Surgery, Medical Microbiology Division, University of Perugia, 06132 Perugia, Italy.ORCID 0000-0001-8334-8325
Stefano PeritoDepartment of Medicine and Surgery, Medical Microbiology Division, University of Perugia, 06132 Perugia, Italy.
Carlo RiccardiDepartment of Medicine and Surgery, Pharmacology Division, University of Perugia, 06132 Perugia, Italy.
Graziella MiglioratiDepartment of Medicine and Surgery, Pharmacology Division, University of Perugia, 06132 Perugia, Italy.
Claudia MonariDepartment of Medicine and Surgery, Medical Microbiology Division, University of Perugia, 06132 Perugia, Italy.ORCID 0000-0002-5027-9367
Simona RonchettiDepartment of Medicine and Surgery, Pharmacology Division, University of Perugia, 06132 Perugia, Italy.ORCID 0000-0002-5639-4243
University of Perugia · IT

Funding

Medical Research Council MR/V033417/1
6 · The paper itself

Abstract

Glucocorticoids are the most powerful anti-inflammatory and immunosuppressive pharmacological drugs available, despite their adverse effects. Glucocorticoid-induced leucine zipper (GILZ) is a glucocorticoid-induced gene that shares several anti-inflammatory properties with glucocorticoids. Although immunosuppressive effects of glucocorticoids on neutrophils remain poorly understood, we previously demonstrated that GILZ suppresses neutrophil activation under glucocorticoid treatment. Here, we sought to explore the regulation of Toll-like receptor 2 (TLR2) by the synthetic glucocorticoid dexamethasone (DEX) on neutrophils and the associated GILZ involvement. Peripheral blood neutrophils were isolated from wild type and GILZ-knock-out (KO) mice. TLR2 was found to be downregulated by the in vivo administration of glucocorticoids in wild type but not in GILZ-KO neutrophils, suggesting the involvement of GILZ in TLR2 downregulation. Accordingly, the TLR2-associated anti-fungal activity of neutrophils was reduced by DEX treatment in wild type but not GILZ-KO neutrophils. Furthermore, GILZ did not interact with NF-κB but was found to bind with STAT5, a pivotal factor in the regulation of TLR2 expression. A similar modulation of TLR2 expression, impaired phagocytosis, and killing activity was observed in circulating human neutrophils treated in vitro with DEX. These results demonstrate that glucocorticoids reduce the ability of neutrophils to respond to infections by downregulating TLR2 via GILZ, thereby reducing critical functions.

Indexed as

AnimalsDexamethasoneDown-RegulationGlucocorticoidsGranulocyte-Macrophage Colony-Stimulating FactorHumansMaleMiceMice, Inbred C57BLMice, KnockoutNeutrophilsSTAT5 Transcription FactorToll-Like Receptor 2Transcription FactorsUp-RegulationDexamethasoneDsip1 protein, mouseGlucocorticoidsGranulocyte-Macrophage Colony-Stimulating FactorSTAT5 Transcription FactorToll-Like Receptor 2Transcription FactorsGILZglucocorticoidsneutrophilTLR2

Identifiers

PMID34571877
PMCPMC8472062
OpenAlexW3197915849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.